Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-17
2008-07-22
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S141000
Reexamination Certificate
active
07402596
ABSTRACT:
Bicycloheteroaryl compounds are disclosed that have a formula represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
REFERENCES:
patent: 2640829 (1953-06-01), Wilson et al.
patent: 3978066 (1976-08-01), Philipp et al.
patent: 6380193 (2002-04-01), Li et al.
patent: 2005/0267202 (2005-12-01), Nguyen et al.
patent: 2005/0277643 (2005-12-01), Kelly et al.
patent: 2006/0135557 (2006-06-01), Nan et al.
patent: 482939 (1992-04-01), None
patent: WO 99/21836 (1999-05-01), None
patent: WO 00/42040 (2000-07-01), None
patent: WO 01/87855 (2001-11-01), None
patent: WO 02/094790 (2002-11-01), None
patent: WO 03/011285 (2003-02-01), None
patent: WO 03/080578 (2003-10-01), None
patent: WO 03/082827 (2003-10-01), None
patent: WO 03/093249 (2003-11-01), None
patent: WO 03/099274 (2003-12-01), None
patent: WO 2004/078176 (2004-09-01), None
patent: WO 2004/108724 (2004-12-01), None
patent: WO 2005/034939 (2005-04-01), None
patent: WO 2005/035503 (2005-04-01), None
patent: WO 2005/066171 (2005-07-01), None
patent: WO 2005/075429 (2005-08-01), None
patent: WO 2005/105814 (2005-11-01), None
patent: WO 2006/030032 (2006-03-01), None
patent: WO 2006/050998 (2006-05-01), None
patent: WO 2006/057270 (2006-06-01), None
patent: WO 2006/066950 (2006-06-01), None
Electron Impact Induced Loss of C-5/C-8 Substituents of 1,2,3,4,-Tetrahydroisoquinolines, VI1): Snythesis and Mass Spectrometric Fragmentation of Dihydroindole Derivatives*)**); 1990, Arch. Pharm. 323, pp. 145-155.
Abstract Only of: Ponomarev, O.A. et al., Acid-base reactions of 1(2H)-isoquinolinone derivatives in the ground and excited states; 1989; Zhurnal Osbschei Khimii 59(6).
Abstract Only of: Doroshenko, A.O., et al., A theoretical approach to the problem of the search for effective luminophors in the isocarbostyril series; 1988; Teoreticheskaya i Eksperimental'naya Khimiya; 24(4).
Chan, WN, et al., Evaluation of a Series of Anticonvulsant 1,2,3,4-Tetrahydrolsoquinollnyl-benzamides, 2000, Bioorganic & Medical Chemistry, vol. 8, pp. 2085-2094.
Kelly Michael G.
Kincaid John
Davis Zinna N
Klauber & Jackson LLC
Renovis, Inc.
LandOfFree
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicycloheteroaryl compounds as P2X7 modulators and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicycloheteroaryl compounds as P2X7 modulators and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3973367